{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:39:32Z","timestamp":1793104772593,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001862","name":"Svenska Forskningsr\u00e5det Formas","doi-asserted-by":"publisher","award":["521-2014-6718"],"award-info":[{"award-number":["521-2014-6718"]}],"id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001862","name":"Svenska Forskningsr\u00e5det Formas","doi-asserted-by":"publisher","award":["2016-01675"],"award-info":[{"award-number":["2016-01675"]}],"id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001862","name":"Svenska Forskningsr\u00e5det Formas","doi-asserted-by":"publisher","award":["2020-02129"],"award-info":[{"award-number":["2020-02129"]}],"id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","award":["FoUI-955284"],"award-info":[{"award-number":["FoUI-955284"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","award":["FoUI-953887"],"award-info":[{"award-number":["FoUI-953887"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s40121-022-00626-8","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T21:02:22Z","timestamp":1649365342000},"page":"1103-1116","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Novel Naturally Occurring Dipeptides and Single-Stranded Oligonucleotide Act as Entry Inhibitors and Exhibit a Strong Synergistic Anti-HIV-1 Profile"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9987-395X","authenticated-orcid":false,"given":"Rafael","family":"Ce\u00f1a-Diez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamalendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Lena","family":"Spetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"S\u00f6nnerborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,7]]},"reference":[{"issue":"2","key":"626_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1089\/adt.2017.777","volume":"15","author":"C Giroud","year":"2017","unstructured":"Giroud C, Du Y, Marin M, et al. Screening and functional profiling of small-molecule HIV-1 entry and fusion inhibitors. Assay Drug Dev Technol. 2017;15(2):53\u201363. https:\/\/doi.org\/10.1089\/adt.2017.777.","journal-title":"Assay Drug Dev Technol"},{"issue":"24","key":"626_CR2","doi-asserted-by":"publisher","first-page":"9403","DOI":"10.3390\/ijms21249403","volume":"21","author":"I Relano-Rodriguez","year":"2020","unstructured":"Relano-Rodriguez I, Munoz-Fernandez MA. Emergence of nanotechnology to fight HIV sexual transmission: the trip of G2\u2013S16 polyanionic carbosilane dendrimer to possible pre-clinical trials. Int J Mol Sci. 2020;21(24):9403. https:\/\/doi.org\/10.3390\/ijms21249403.","journal-title":"Int J Mol Sci"},{"issue":"14","key":"626_CR3","doi-asserted-by":"publisher","first-page":"5036","DOI":"10.1073\/pnas.0307953101","volume":"101","author":"Z Si","year":"2004","unstructured":"Si Z, Madani N, Cox JM, et al. Small-molecule inhibitors of HIV-1 entry block receptor-induced conformational changes in the viral envelope glycoproteins. Proc Natl Acad Sci USA. 2004;101(14):5036\u201341. https:\/\/doi.org\/10.1073\/pnas.0307953101.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"626_CR4","doi-asserted-by":"publisher","first-page":"5698","DOI":"10.1073\/pnas.96.10.5698","volume":"96","author":"M Baba","year":"1999","unstructured":"Baba M, Nishimura O, Kanzaki N, et al. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc Natl Acad Sci USA. 1999;96(10):5698\u2013703. https:\/\/doi.org\/10.1073\/pnas.96.10.5698.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"626_CR5","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.1128\/AAC.49.11.4721-4732.2005","volume":"49","author":"P Dorr","year":"2005","unstructured":"Dorr P, Westby M, Dobbs S, et al. Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Antimicrob Agents Chemother. 2005;49(11):4721\u201332. https:\/\/doi.org\/10.1128\/AAC.49.11.4721-4732.2005.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"626_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1177\/1087057110393333","volume":"16","author":"W Pang","year":"2011","unstructured":"Pang W, Wang RR, Gao YD, et al. A novel enzyme-linked immunosorbent assay for screening HIV-1 fusion inhibitors targeting HIV-1 Gp41 core structure. J Biomol Screen. 2011;16(2):221\u20139. https:\/\/doi.org\/10.1177\/1087057110393333.","journal-title":"J Biomol Screen"},{"issue":"2","key":"626_CR7","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.bmcl.2009.11.076","volume":"20","author":"KD Stewart","year":"2010","unstructured":"Stewart KD, Huth JR, Ng TI, et al. Non-peptide entry inhibitors of HIV-1 that target the gp41 coiled coil pocket. Bioorg Med Chem Lett. 2010;20(2):612\u20137. https:\/\/doi.org\/10.1016\/j.bmcl.2009.11.076.","journal-title":"Bioorg Med Chem Lett"},{"issue":"8","key":"626_CR8","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a016972","volume":"6","author":"P Cossart","year":"2014","unstructured":"Cossart P, Helenius A. Endocytosis of viruses and bacteria. Cold Spring Harb Perspect Biol. 2014;6(8): a016972. https:\/\/doi.org\/10.1101\/cshperspect.a016972.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2","key":"626_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/med.21289","volume":"34","author":"E Vanderlinden","year":"2014","unstructured":"Vanderlinden E, Naesens L. Emerging antiviral strategies to interfere with influenza virus entry. Med Res Rev. 2014;34(2):301\u201339. https:\/\/doi.org\/10.1002\/med.21289.","journal-title":"Med Res Rev"},{"key":"626_CR10","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3389\/fimmu.2020.01112","volume":"11","author":"JT Martinsen","year":"2020","unstructured":"Martinsen JT, Gunst JD, Hojen JF, Tolstrup M, Sogaard OS. The use of toll-like receptor agonists in HIV-1 cure strategies. Front Immunol. 2020;11:1112. https:\/\/doi.org\/10.3389\/fimmu.2020.01112.","journal-title":"Front Immunol"},{"issue":"2","key":"626_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/08830185.2016.1261318","volume":"36","author":"S Tartey","year":"2017","unstructured":"Tartey S, Takeuchi O. Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells. Int Rev Immunol. 2017;36(2):57\u201373. https:\/\/doi.org\/10.1080\/08830185.2016.1261318.","journal-title":"Int Rev Immunol"},{"issue":"1","key":"626_CR12","doi-asserted-by":"publisher","first-page":"15841","DOI":"10.1038\/s41598-018-33960-4","volume":"8","author":"P Jarver","year":"2018","unstructured":"Jarver P, Dondalska A, Poux C, et al. Single-stranded nucleic acids regulate TLR3\/4\/7 activation through interference with clathrin-mediated endocytosis. Sci Rep. 2018;8(1):15841. https:\/\/doi.org\/10.1038\/s41598-018-33960-4.","journal-title":"Sci Rep"},{"issue":"4","key":"626_CR13","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/ni1569","volume":"9","author":"JC Kagan","year":"2008","unstructured":"Kagan JC, Su T, Horng T, Chow A, Akira S, Medzhitov R. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol. 2008;9(4):361\u20138. https:\/\/doi.org\/10.1038\/ni1569.","journal-title":"Nat Immunol"},{"key":"626_CR14","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.3389\/fimmu.2019.02161","volume":"10","author":"C Poux","year":"2019","unstructured":"Poux C, Dondalska A, Bergenstrahle J, et al. A single-stranded oligonucleotide inhibits toll-like receptor 3 activation and reduces influenza A (H1N1) infection. Front Immunol. 2019;10:2161. https:\/\/doi.org\/10.3389\/fimmu.2019.02161.","journal-title":"Front Immunol"},{"key":"626_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.580547","volume":"11","author":"SA Palsson","year":"2020","unstructured":"Palsson SA, Dondalska A, Bergenstrahle J, et al. Single-stranded oligonucleotide-mediated inhibition of respiratory syncytial virus infection. Front Immunol. 2020;11: 580547. https:\/\/doi.org\/10.3389\/fimmu.2020.580547.","journal-title":"Front Immunol"},{"key":"626_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.coviro.2019.05.010","volume":"38","author":"C Lopez-Galindez","year":"2019","unstructured":"Lopez-Galindez C, Pernas M, Casado C, Olivares I, Lorenzo-Redondo R. Elite controllers and lessons learned for HIV-1 cure. Curr Opin Virol. 2019;38:31\u20136. https:\/\/doi.org\/10.1016\/j.coviro.2019.05.010.","journal-title":"Curr Opin Virol"},{"key":"626_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fimmu.2018.00019","volume":"9","author":"K Noyan","year":"2018","unstructured":"Noyan K, Nguyen S, Betts MR, Sonnerborg A, Buggert M. Human immunodeficiency virus type-1 elite controllers maintain low co-expression of inhibitory receptors on CD4+ T cells. Front Immunol. 2018;9:19. https:\/\/doi.org\/10.3389\/fimmu.2018.00019.","journal-title":"Front Immunol"},{"issue":"18","key":"626_CR18","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00479-21","volume":"95","author":"M Sperk","year":"2021","unstructured":"Sperk M, Ambikan AT, Ray S, et al. Fecal metabolome signature in the HIV-1 elite control phenotype: enrichment of dipeptides acts as an HIV-1 antagonist but a Prevotella agonist. J Virol. 2021;95(18): e0047921. https:\/\/doi.org\/10.1128\/JVI.00479-21.","journal-title":"J Virol"},{"key":"626_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jcv.2018.12.007","volume":"111","author":"I Vicenti","year":"2019","unstructured":"Vicenti I, Lai A, Giannini A, et al. Performance of Geno2Pheno[coreceptor] to infer coreceptor use in human immunodeficiency virus type 1 (HIV-1) subtype A. J Clin Virol. 2019;111:12\u20138. https:\/\/doi.org\/10.1016\/j.jcv.2018.12.007.","journal-title":"J Clin Virol"},{"issue":"9","key":"626_CR20","doi-asserted-by":"publisher","first-page":"806","DOI":"10.3390\/v11090806","volume":"11","author":"SG Aralaguppe","year":"2019","unstructured":"Aralaguppe SG, Ambikan AT, Ashokkumar M, et al. MiDRMpol: a high-throughput multiplexed amplicon sequencing workflow to quantify HIV-1 drug resistance mutations against protease, reverse transcriptase, and integrase inhibitors. Viruses. 2019;11(9):806. https:\/\/doi.org\/10.3390\/v11090806.","journal-title":"Viruses"},{"issue":"10","key":"626_CR21","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1093\/jac\/dky256","volume":"73","author":"DT Njenda","year":"2018","unstructured":"Njenda DT, Aralaguppe SG, Singh K, et al. Antiretroviral potency of 4\u2032-ethnyl-2\u2032-fluoro-2\u2032-deoxyadenosine, tenofovir alafenamide and second-generation NNRTIs across diverse HIV-1 subtypes. J Antimicrob Chemother. 2018;73(10):2721\u20138. https:\/\/doi.org\/10.1093\/jac\/dky256.","journal-title":"J Antimicrob Chemother"},{"key":"626_CR22","doi-asserted-by":"crossref","unstructured":"Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 1984;22:27\u201355. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6382953.","DOI":"10.1016\/0065-2571(84)90007-4"},{"issue":"2","key":"626_CR23","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"TC Chou","year":"2010","unstructured":"Chou TC. Drug combination studies and their synergy quantification using the Chou\u2013Talalay method. Cancer Res. 2010;70(2):440\u20136. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-1947.","journal-title":"Cancer Res"},{"issue":"2","key":"626_CR24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1586\/14787210.4.2.291","volume":"4","author":"E De Clercq","year":"2006","unstructured":"De Clercq E. Potential antivirals and antiviral strategies against SARS coronavirus infections. Expert Rev Anti Infect Ther. 2006;4(2):291\u2013302. https:\/\/doi.org\/10.1586\/14787210.4.2.291.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"34","key":"626_CR25","doi-asserted-by":"publisher","first-page":"21988","DOI":"10.1074\/jbc.273.34.21988","volume":"273","author":"C Callebaut","year":"1998","unstructured":"Callebaut C, Blanco J, Benkirane N, et al. Identification of V3 loop-binding proteins as potential receptors implicated in the binding of HIV particles to CD4(+) cells. J Biol Chem. 1998;273(34):21988\u201397. https:\/\/doi.org\/10.1074\/jbc.273.34.21988.","journal-title":"J Biol Chem"},{"key":"626_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ejphar.2017.05.060","volume":"811","author":"P Garcia-Broncano","year":"2017","unstructured":"Garcia-Broncano P, Cena-Diez R, de la Mata FJ, Gomez R, Resino S, Munoz-Fernandez MA. Efficacy of carbosilane dendrimers with an antiretroviral combination against HIV-1 in the presence of semen-derived enhancer of viral infection. Eur J Pharmacol. 2017;811:155\u201363. https:\/\/doi.org\/10.1016\/j.ejphar.2017.05.060.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"626_CR27","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1186\/s12885-020-06782-9","volume":"20","author":"G Lindstrom","year":"2020","unstructured":"Lindstrom G, Jonathan H, Friedman R. The effects of combination treatments on drug resistance in chronic myeloid leukaemia: an evaluation of the tyrosine kinase inhibitors axitinib and asciminib. BMC Cancer. 2020;20(1):397. https:\/\/doi.org\/10.1186\/s12885-020-06782-9.","journal-title":"BMC Cancer"},{"key":"626_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.104697","volume":"174","author":"S Theerawatanasirikul","year":"2020","unstructured":"Theerawatanasirikul S, Kuo CJ, Phetcharat N, Lekcharoensuk P. In silico and in vitro analysis of small molecules and natural compounds targeting the 3CL protease of feline infectious peritonitis virus. Antiviral Res. 2020;174: 104697. https:\/\/doi.org\/10.1016\/j.antiviral.2019.104697.","journal-title":"Antiviral Res"},{"issue":"5","key":"626_CR29","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jcma.2017.11.007","volume":"81","author":"HL You","year":"2018","unstructured":"You HL, Huang CC, Chen CJ, Chang CC, Liao PL, Huang ST. Anti-pandemic influenza A (H1N1) virus potential of catechin and gallic acid. J Chin Med Assoc. 2018;81(5):458\u201368. https:\/\/doi.org\/10.1016\/j.jcma.2017.11.007.","journal-title":"J Chin Med Assoc"},{"issue":"3","key":"626_CR30","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/QAD.0000000000002078","volume":"33","author":"KJ Hill","year":"2019","unstructured":"Hill KJ, Rogers LC, Njenda DT, et al. Strain-specific effect on biphasic DNA binding by HIV-1 integrase. AIDS. 2019;33(3):588\u201392. https:\/\/doi.org\/10.1097\/QAD.0000000000002078.","journal-title":"AIDS"},{"issue":"8","key":"626_CR31","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3390\/v12080838","volume":"12","author":"A Kirichenko","year":"2020","unstructured":"Kirichenko A, Lapovok I, Baryshev P, et al. Genetic features of HIV-1 integrase sub-subtype A6 predominant in Russia and predicted susceptibility to INSTIs. Viruses. 2020;12(8):838. https:\/\/doi.org\/10.3390\/v12080838.","journal-title":"Viruses"},{"issue":"3","key":"626_CR32","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/01.qai.0000209899.05126.e4","volume":"41","author":"DA van de Vijver","year":"2006","unstructured":"van de Vijver DA, Wensing AM, Angarano G, et al. The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes. J Acquir Immune Defic Syndr. 2006;41(3):352\u201360. https:\/\/doi.org\/10.1097\/01.qai.0000209899.05126.e4.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"626_CR33","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/jac\/dkaa474","volume":"76","author":"M Gartland","year":"2021","unstructured":"Gartland M, Zhou N, Stewart E, et al. Susceptibility of global HIV-1 clinical isolates to fostemsavir using the PhenoSense(R) Entry assay. J Antimicrob Chemother. 2021;76(3):648\u201352. https:\/\/doi.org\/10.1093\/jac\/dkaa474.","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"626_CR34","doi-asserted-by":"publisher","first-page":"44","DOI":"10.17116\/terarkh2017891144-49","volume":"89","author":"IA Lapovok","year":"2017","unstructured":"Lapovok IA, Lopatukhin AE, Kireev DE, et al. Molecular epidemiological analysis of HIV-1 variants circulating in Russia in 1987\u20132015. Ter Arkh. 2017;89(11):44\u20139. https:\/\/doi.org\/10.17116\/terarkh2017891144-49.","journal-title":"Ter Arkh"},{"issue":"10","key":"626_CR35","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1089\/aid.2008.0119","volume":"24","author":"C Riva","year":"2008","unstructured":"Riva C, Romano L, Saladini F, et al. Identification of a possible ancestor of the subtype A1 HIV Type 1 variant circulating in the former Soviet Union. AIDS Res Hum Retroviruses. 2008;24(10):1319\u201325. https:\/\/doi.org\/10.1089\/aid.2008.0119.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"626_CR36","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002883","author":"AG Cutrell","year":"2021","unstructured":"Cutrell AG, Schapiro JM, Perno CF, et al. Predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis across three phase 3 studies. AIDS. 2021. https:\/\/doi.org\/10.1097\/QAD.0000000000002883.","journal-title":"AIDS"},{"issue":"1","key":"626_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12879-016-2163-1","volume":"17","author":"AW Kalu","year":"2017","unstructured":"Kalu AW, Telele NF, Gebreselasie S, et al. Monophylogenetic HIV-1C epidemic in Ethiopia is dominated by CCR5-tropic viruses-an analysis of a prospective country-wide cohort. BMC Infect Dis. 2017;17(1):37. https:\/\/doi.org\/10.1186\/s12879-016-2163-1.","journal-title":"BMC Infect Dis"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-022-00626-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-022-00626-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-022-00626-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T06:27:44Z","timestamp":1653114464000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-022-00626-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,7]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["626"],"URL":"https:\/\/doi.org\/10.1007\/s40121-022-00626-8","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,7]]},"assertion":[{"value":"10 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}